1-hour glycemia predicts future dysglycemia in normoglycemic subjects
In subjects who are initially normoglycemic, glycemia measured one hour after 75 grams of glucose predicted prediabetes and diabetes better than fasting values, two-hour values, and glycated hemoglobin. Independent cohorts and physiological studies support this association, but do not demonstrate that the one-hour value alone should replace diagnostic criteria.
- Published 12/11/2026
- Updated 15/11/2026
- Article history
ABSTRACT
The original study examined whether blood glucose values obtained during an oral glucose tolerance test (OGTT, a test in which glucose and sometimes insulin are measured after glucose intake) can predict the onset of glycemic regulation disorders in people initially classified as having normal glucose tolerance. In 1,356 subjects with at least one follow-up OGTT, 1-hour glycemia showed superior discriminatory capacity compared to fasting glycemia, 2-hour glycemia, and glycated hemoglobin in predicting future prediabetes or diabetes.
The research contributes to the passage from "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, according to which the 1-hour value captures a phase in which the initial insulin response and tissue sensitivity to insulin are under particular stress. Independent cohorts confirm the association between elevated 1-hour glycemia and a higher future probability of diabetes; physiological studies also show lower insulin sensitivity and less effective beta-cell function. However, this prognostic and mechanistic evidence alone does not establish that the 1-hour value should replace all other diagnostic criteria.
Analyzed study
The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects
DOI: 10.1016/j.jdiacomp.2017.07.017
PMID: 28916170
The research question was whether, in people with normal glucose tolerance, fasting glycemia, or glycemia measured one hour or two hours after an OGTT, better predicted the subsequent onset of dysglycemia. The authors used the term dysglycemia to indicate the onset of prediabetes or diabetes according to World Health Organization criteria.
The hypothesis was that one-hour glycemia might contain more prognostic information than conventional parameters. This question is relevant to this section of the book because it addresses the central point of the narrative: an early glycemic peak after a glucose load can reveal future metabolic risk even when the initial classification is normal.
The study can compare how accurately different glycemic values distinguish, over time, between those who will and will not develop dysglycemia. However, it cannot prove that elevated one-hour glycemia causes diabetes, nor can it define on its own which threshold should be adopted in clinical practice.
Materials and methods of the original study
An analysis of electronic health records was conducted on individuals who underwent an OGTT between 1991 and 2016 at a specialized diabetes center. A total of 1,356 subjects with normal glucose tolerance at their first examination and at least one subsequent follow-up OGTT were selected.
The researchers compared fasting plasma glycemia, as well as glycemia at one hour and two hours, both individually and in combination. They also compared one-hour glycemia with glycated hemoglobin—an indicator of average glucose exposure over the preceding months—and with the combination of glycated hemoglobin and fasting glycemia.
The primary outcome was the subsequent onset of prediabetes or diabetes. Predictive capacity was evaluated using the area under the ROC curve, or AUC: a higher value indicates a better ability to distinguish between people who will develop the outcome and those who will not. Detailed exclusion criteria, distribution by sex and age, glucose concentrations used as thresholds, and multivariate adjustment analyses are not reported in the available material, which contains only the abstract.
Results
During a median follow-up of 3.5 years, 318 out of 1,356 participants, or 23.4%, developed prediabetes. During a median follow-up of 5.6 years, 134 participants, or 10%, developed diabetes. Median times indicate the midpoint of the observed time distribution and do not mean that every participant was followed for exactly that duration.
For the prediction of prediabetes, one-hour glycemia achieved an AUC of 0.684, which was higher than that of fasting glycemia (0.560) and two-hour glycemia (0.644). For the prediction of diabetes, the AUC for one-hour glycemia was 0.716, compared to 0.593 for fasting glycemia and 0.618 for two-hour glycemia. In practical terms, the one-hour value better distinguished those who would develop future glycemic impairment.
Adding fasting glycemia or two-hour glycemia to one-hour glycemia did not significantly improve the AUC compared to one-hour glycemia alone. Also for diabetes, one-hour glycemia predicted the outcome better than glycated hemoglobin and the combination of glycated hemoglobin and fasting glycemia. Confidence intervals, exact P-values, analyzed thresholds, and estimates adjusted for potential confounding factors are not reported in the available material.
Interpretation
The main finding suggests that, after glucose intake, a measurement taken at one hour can capture differences in how the body rapidly handles a sugar load. This is consistent with the fact that, at that stage, an adequate early insulin secretion must work in tandem with a good response to insulin from the muscles, liver, and adipose tissue.
The part of the book's narrative that is actually supported by the study is prognostic: among individuals who are initially normoglycemic, a more informative one-hour glycemia better identifies those who will later develop prediabetes or diabetes compared to the parameters compared. The study did not directly measure early insulin secretion, peripheral insulin sensitivity, or pancreatic beta-cell function. The link to these mechanisms is therefore pathophysiologically plausible, but requires additional specific evidence.
Independent supporting evidence
Initial independent confirmation comes from the San Antonio Heart Study. In 1,611 individuals without baseline diabetes, followed for 7-8 years, one-hour glycemia during an OGTT helped identify subjects with normal glucose tolerance but at high future risk of diabetes. The model that included one-hour glycemia, fasting glycemia, and metabolic syndrome maintained its ability to stratify risk independently of two-hour glycemia. This directly confirms the prognostic shift in the narrative, although it does not prove that the one-hour value is the only necessary parameter [1].
A second cohort, consisting of 5,703 Korean adults with normal glucose tolerance followed for 12 years, reinforced the generalizability of the association. 10.3% developed diabetes; the AUC for one-hour glycemia was 0.74, higher than that for fasting glycemia (0.61) and two-hour glycemia (0.63). After adjusting for the risk factors considered by the authors, a one-hour value equal to or greater than 8.0 mmol/L was associated with a 2.84-fold higher risk of diabetes and lower beta-cell function. This is longitudinal confirmation in humans, but it remains an observational association and not proof of causality [2].
The pathophysiological link mentioned in the book is supported by a clinical-metabolic study of 305 non-diabetic offspring of people with type 2 diabetes. Among participants with normal glucose tolerance, those with one-hour glycemia equal to or greater than 155 mg/dL showed lower insulin sensitivity and reduced beta-cell function compared to subjects with a lower one-hour value. Beta cells are the pancreatic cells that produce insulin; a less effective response from them makes it more difficult to contain the rise in glycemia after a glucose load. This result supports the proposed mechanism, but it is cross-sectional: it describes differences present at the time of the examination and does not prove that such differences necessarily determine future diabetes [3].
Conflicting evidence
No directly conflicting evidence of sufficient relevance has been identified; this does not prove the absence of contrary results.
The main caution concerns clinical interpretation: different studies have used different populations, follow-up durations, and one-hour glycemia thresholds. Furthermore, the fact that a parameter improves statistical prediction does not automatically equate to its adoption as a complete substitute for fasting glycemia, two-hour glycemia, or glycated hemoglobin. The comparability of the results is therefore good in terms of the direction of the association, but less defined regarding the choice of a single universal threshold value.
Summary table of evidence
The table distinguishes the study that is the subject of the review from the independent publications used to confirm the prognostic and pathophysiological passage in the book chapter.
| Reference | Study type | Population or model | Main result | Direction of evidence | Strength of evidence |
|---|---|---|---|---|---|
| Original study | Retrospective analysis of medical records with follow-up | 1,356 subjects with normal glucose tolerance | One-hour glycemia had a higher AUC compared to fasting, two-hour, and HbA1c levels in predicting future dysglycemia. | direct confirmation | moderate |
| [1] | Prospective cohort | 1,611 people without diabetes, including people with normal glucose tolerance | One-hour glycemia identified subjects at higher future risk of diabetes independently of two-hour glycemia. | direct confirmation | moderate |
| [2] | Community-based prospective cohort | 5,703 Korean adults with normal glucose tolerance, 12-year follow-up | One-hour glycemia predicted diabetes better than fasting and two-hour values; elevated values were associated with higher risk. | direct confirmation | high |
| [3] | Cross-sectional clinical-metabolic study | 305 non-diabetic offspring of people with type 2 diabetes | Elevated one-hour glycemia was associated with lower insulin sensitivity and reduced beta-cell function. | biologically consistent evidence | moderate |
Confirmation of the evidence
Claim in the book
In the section dedicated to one-hour plasma glycemia, "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi states that this value reflects the early metabolic response to glucose and represents a moment when initial insulin secretion and peripheral insulin sensitivity are particularly challenged. The text links this characteristic to the ability of the one-hour value to anticipate the risk of future dysglycemia.
Oral glucose load → early insulin response and insulin sensitivity → higher one-hour glycemia → greater future probability of prediabetes or diabetes
The publication subject to the Evidence Review was used in the book to support the following passage: in people initially with normal glucose tolerance, glycemia measured one hour after a glucose load predicts the future onset of prediabetes and diabetes better than fasting glycemia, two-hour glycemia, and glycated hemoglobin.
The correspondence with the paragraph is direct on a prognostic level: the original study precisely compares the glycemia values of the OGTT and observes that the one-hour value better discriminates future dysglycemia. The pathophysiological link recalled by "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi is instead completed by a chain of independent evidence. The San Antonio Heart Study cohort confirms that one-hour glycemia identifies non-diabetic individuals, including those with normal glucose tolerance, at higher risk of future diabetes [1]. The Korean cohort confirms in another population that the one-hour value has a superior predictive capacity compared to fasting and two-hour values, and that an elevated value is associated with lower beta-cell function and a higher probability of incident diabetes [2]. Finally, the clinical-metabolic study by Marini and colleagues documents that, even before a diabetes diagnosis, elevated one-hour glycemia coexists with lower insulin sensitivity and reduced beta-cell function [3].
Overall, the literature supports both the prognostic direction of the narrative and its biological coherence. However, the mechanism was not measured directly in the original study, and none of the observational cohorts demonstrate that modifying one-hour glycemia in isolation prevents diabetes.
Overall level of confirmation
STRONG CONFIRMATION
The finding is supported by the original study and multiple independent longitudinal cohorts in humans across different populations, while clinical-metabolic studies confirm consistency with reduced insulin sensitivity and beta-cell function. The evidence remains primarily prognostic and observational, not causal.
Conclusions
The study analyzed shows that, in individuals initially considered normoglycemic, one-hour glycemia during an OGTT predicted the subsequent onset of prediabetes and diabetes better than the compared values. This finding is well supported by independent cohorts and appears consistent with early alterations in insulin sensitivity and beta-cell function.
The pathophysiological narrative is therefore robustly confirmed, but with an important limitation: predictive capacity does not demonstrate causality and does not, by itself, equate to the definition of a substitute diagnostic criterion. Further prospective validation in different clinical settings is necessary to establish how to integrate the one-hour value into the individual assessment of metabolic risk.
Overall assessment
The relationship between elevated one-hour glycemia and increased future risk of dysglycemia is fairly well supported by independent prospective cohorts. The biological mechanism is confirmed at a clinical-metabolic level by associations with lower insulin sensitivity and beta-cell function. However, the diagnostic integration of this parameter requires further, contextualized validation.
References
[1] One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
[2] One‐hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12‐year community‐based cohort study
[3] Insulin Sensitivity, b-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels
Editorial note
Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.
The manuscript was also subject to independent peer review prior to publication.
To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.